MANIPULATION OF GRAFT-VERSUS-HOST DISEASE FOR A GRAFT-VERSUS-LEUKEMIA EFFECT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN AKR MICE WITH SPONTANEOUS LEUKEMIA LYMPHOMA

被引：60
|
作者：
TRUITT, RL [1 ]
SHIH, CCY [1 ]
LEFEVER, AV [1 ]
机构：
[1] MILWAUKEE CHILDRENS HOSP,MILWAUKEE,WI 53233
来源：
TRANSPLANTATION | 1986年 / 41卷 / 03期
关键词：
D O I：
10.1097/00007890-198603000-00005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：301 / 310
页数：10
相关论文
共 50 条
  • [21] EFFECTOR-CELLS OF GRAFT-VERSUS-HOST DISEASE, HOST-RESISTANCE, AND THE GRAFT-VERSUS-LEUKEMIA EFFECT - SUMMARY OF A WORKSHOP ON BONE-MARROW TRANSPLANTATION
    RINGDEN, O
    DEEG, HJ
    BESCHORNER, W
    SLAVIN, S
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2758 - 2761
  • [22] Failure of cyclosporine to induce graft-versus-host disease or graft-versus-leukemia after syngeneic murine bone marrow transplantation
    Singhal, S
    VourkaKarussis, U
    Weiss, L
    Mehta, J
    Slavin, S
    BLOOD, 1995, 86 (10) : 3895 - 3895
  • [23] Cyclosporine does not induce graft-versus-host disease or graft-versus-leukemia after syngeneic marrow transplantation in mice.
    Singhal, S
    VourkaKarussis, U
    Weiss, L
    Mehta, J
    Slavin, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 149 - 149
  • [24] Graft-versus-Leukemia Induced by Graft-versus-Host Disease Early After Allogeneic Bone Marrow Transplantation in Children With Detectable Levels of Residual Acute Lymphoblastic Leukemia Prior to Transplantation
    Lankester, Arjan C.
    Bierings, Marc
    van der Velden, Vincent H. J.
    Revesz, Tom
    Wijkhuis, Annemarie
    van Wering, Elisabeth R.
    van Tol, Maarten J. D.
    Egeler, Maarten R.
    van Dongen, Jacques J.
    Schilham, Marco W.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (04) : 242 - 243
  • [25] Graft-versus-leukemia induced by graft-versus-host disease early after allogeneic bone marrow transplantation in children with detectable levels of residual acute lymphoblastic leukemia prior to transplantation
    Bierings, M.
    Lankester, A.
    van der Velden, V. J. V.
    van Wering, E.
    Revesz, T.
    Wijkhuis, A.
    van Dongen, J. J. M.
    Van Tol, M.
    Egeler, M.
    Schilham, M. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 156 - 156
  • [26] ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PERREAULT, C
    GYGER, M
    BOILEAU, J
    BONNY, Y
    COUSINEAU, S
    LACOMBE, M
    LAVALLEE, R
    TAWIL, E
    DANGELO, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 129 (09) : 969 - 974
  • [27] Human Mesenchymal Stem Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia in Murine Allogeneic Bone Marrow Transplantation
    Auletta, Jeffery J.
    Eid, Saada
    Keller, Matthew
    Metheny, Leland
    Guardia-Wolff, Rocio
    Lee, Zhenghong
    Solchaga, Luis A.
    Cooke, Kenneth R.
    BLOOD, 2011, 118 (21) : 831 - 832
  • [28] LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
    Cooke, KR
    Gerbitz, A
    Crawford, JM
    Teshima, T
    Hill, GR
    Tesolin, A
    Rossignol, DP
    Ferrara, JLM
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12): : 1581 - 1589
  • [29] IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation
    Teshima, T
    Hill, GR
    Pan, LY
    Brinson, YS
    van den Brink, MRM
    Cooke, KR
    Ferrara, JLM
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03): : 317 - 325
  • [30] Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect
    Alyea, Edwin P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 239 - 250
12345